Quick answers
- What is Inspra?
- Inspra is a brand name of Eplerenone, a prescription medicine. The FDA NDC Directory lists 2 Inspra products in 2 strengths and forms.
- Who makes Inspra?
- Upjohn holds the FDA application for Inspra (NDA021437, approved September 27, 2002).
- Is there a generic or store brand of Inspra?
- Yes. The FDA NDC Directory lists 10 other products with the same active ingredients, strength and form as a Inspra product, 10 of them generic. Ask your pharmacist whether one is right for you.
- Has Inspra been recalled?
- No recall linked to Inspra products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Inspra is
Each Inspra product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Eplerenone · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| eplerenone 25 mg tablet, film coated (oral) | Inspra | 6 products, 6 companies | DailyMed |
| eplerenone 50 mg tablet, film coated (oral) | Inspra | 4 products, 4 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Eplerenone →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021437 | Upjohn | September 27, 2002 | 2 |
Companies that list Inspra
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Inspra products.
- Viatris Specialty LLC2 products
Recalls
No recall linked to Inspra products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.